Jay H. Shubrook, DO: Hi. I am Jay Shubrook, family physician and professor at Touro University California. We are here in Orlando, Florida, at the 78th Scientific Sessions of the American Diabetes ...
MISSISSAUGA, ON, Nov. 21, 2017 /CNW/ - Novo Nordisk announced today that Health Canada has approved a product monograph update for Victoza ® (liraglutide). Victoza ® is now approved to reduce the ...
Dexcom CGM use is proven to improve glycemic control 1,2 and can reduce the risk of costly long-term diabetes-related complications compared to fingerstick monitoring. 3 BURNABY, British ...
MISSISSAUGA, ON, June 4, 2014 /CNW/ - Novo Nordisk today announces that the Québec government has approved the inclusion of Victoza(R) (liraglutide), the first once-daily human glucagon-like peptide-1 ...
The ADA releases its first independent recommendations on physical activity and exercise for all patients with diabetes. The American Diabetes Association (ADA) has issued updated guidelines for all ...
As the structure grows internally for Kidney Disease: Improving Global Outcomes, the nonprofit organization has work in the pipeline that includes new guidelines under development, outdated guidelines ...
International Indigenous Policy Journal, Vol. 2, No. 1, Health and Well-Being (May 2011), pp. 1-16 (18 pages) Type 2 diabetes mellitus is a progressive metabolic disorder that affects Aboriginal ...
Not enough men in Alberta, Canada -- especially those in their 40s -- are getting tested for diabetes, putting them at risk for heart disease, cancer and other complications, according to new ...
The World Health Organization has added key GLP-1 drugs, semaglutide and tirzepatide, to its Essential Medicines List for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback